ArticleAmerican journal of translational research2021

TANK-binding kinase 1 inhibitor GSK8612 enhances daunorubicin sensitivity in acute myeloid leukemia cells via the AKT-CDK2 pathway.

Siyu Chen et al.PubMed ↗Full text ↗

No numbers read from the abstract.